InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,307.01
(
-0.27%
)
US TECH 100
18,307.60
(
0.41%
)
Dow Jones
39,671.04
(
-0.51%
)
Brent Oil
81.29
(
-0.30%
)
Bitcoin
69,413.33
(
0.45%
)

Replies to post #2362 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #2362 on Enanta Pharmaceuticals Inc (ENTA)

Jake2234

11/26/22 2:50 PM

#2363 RE: vinmantoo #2362

There will be no phase 3 in high risk pts. Due to the availability of molnupiravir and Paxlovid, it is unethical for a physician to give a placebo to a high risk patient. There is no regulatory framework for this.